Drug-maker Jubilant Life Sciences today announced a price increase of 18 per cent for Niacin feed-grade, with immediate effect.
Jubilant Life Sciences, ranked among the largest makers of vitamin B3 (Niacin & Niacinamide) in the world, announced a price increase of 18 per cent for Niacin feed-grade, with immediate effect, for non-contract customers and wherever existing contracts permit, a company statement said.
The company's nutrition business is backward integrated up to the initial raw material stage with global scale of operations.
Jubilant Life Sciences is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), solid dosage formulations, radio pharmaceuticals, allergy therapy products and life science ingredients.
It also provides services in contract manufacturing of sterile injectables and ointments, creams and liquids and drug discovery and development.
The company has 10 manufacturing facilities in India, the US and Canada and a team of over 6,300 people across the globe.
